Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ANIXA BIOSCIENCES INC (ANIX) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.ANIXA BIOSCIENCES INC is one of 951 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ANIXA BIOSCIENCES INC is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for ANIX's full-year earnings has moved 2.6% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.Based on the latest available data, ANIX has gained about 71.1% so far this year. Meanwhile, stocks in the Medical group have gained about 0.8% on average. This means that ANIXA BIOSCIENCES INC is performing better than its sector in terms of year-to-date returns.Another Medical stock, which has outperformed the sector so far this year, is Boston Scientific (BSX). The stock has returned 10.7% year-to-date.Over the past three months, Boston Scientific's consensus EPS estimate for the current year has increased 2%. The stock currently has a Zacks Rank #2 (Buy).To break things down more, ANIXA BIOSCIENCES INC belongs to the Medical - Biomedical and Genetics industry, a group that includes 469 individual companies and currently sits at #97 in the Zacks Industry Rank. On average, this group has gained an average of 10.2% so far this year, meaning that ANIX is performing better in terms of year-to-date returns. On the other hand, Boston Scientific belongs to the Medical - Products industry. This 84-stock industry is currently ranked #150. The industry has moved +1.4% year to date.Going forward, investors interested in Medical stocks should continue to pay close attention to ANIXA BIOSCIENCES INC and Boston Scientific as they could maintain their solid performance.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ANIXA BIOSCIENCES INC (ANIX): Free Stock Analysis Report Boston Scientific Corporation (BSX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks